AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,504,000 | +1.7% | 300,000 | -26.4% | 4.20% | +15.8% |
| Q3 2022 | $18,188,000 | -44.1% | 407,600 | -52.0% | 3.62% | -38.9% |
| Q2 2022 | $32,555,000 | +2061.7% | 850,000 | +4544.8% | 5.94% | +4846.7% |
| Q2 2020 | $1,506,000 | -95.1% | 18,300 | -96.5% | 0.12% | -94.8% |
| Q1 2020 | $30,886,000 | +970.9% | 525,000 | +1781.7% | 2.32% | +397.4% |
| Q4 2019 | $2,884,000 | – | 27,900 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |